文献速递糖尿病

遗传驱动的血糖升高独立于2型糖尿病增加冠状动脉疾病风险

Genetically Driven Hyperglycemia Increases Risk of Coronary Artery Disease Separately From Type 2 Diabetes.
PubMed 文献 · Diabetes Care · 2017-03-15

本研究采用孟德尔随机化分析,利用空腹血糖(n=133,010名无糖尿病参与者)和冠状动脉疾病(63,746例病例和130,681例对照)的大规模全基因组关联研究汇总数据,检验遗传性血糖升高是否独立于2型糖尿病整体风险增加冠状动脉疾病风险。结果显示,空腹血糖每升高1 mmol/L,冠状动脉疾病比值比为1.43(95%CI 1.14-1.79),排除异质性和多效性变异后为1.33(95%CI 1.02-1.73);12个空腹血糖升高变异未显著增加2型糖尿病风险(OR 1.05 [95%CI 0.91-1.23]),且2型糖尿病患病率在各空腹血糖遗传风险评分五分位间保持恒定(P=0.72)。结论支持遗传性高血糖易感性独立于2型糖尿病和其他冠状动脉疾病风险因素增加冠状动脉疾病风险。

要点

  • 空腹血糖每升高1 mmol/L,冠状动脉疾病比值比为1.43(95%CI 1.14-1.79)。
  • 排除异质性和多效性变异后,比值比为1.33(95%CI 1.02-1.73)。
  • 12个空腹血糖升高变异未显著增加2型糖尿病风险(OR 1.05 [95%CI 0.91-1.23])。

核心结论

  • 数据支持遗传性高血糖易感性独立于2型糖尿病和其他冠状动脉疾病风险因素增加冠状动脉疾病风险。
  • 这些发现提示调节血糖可能提供心血管益处。

研究设计与样本

  • 孟德尔随机化分析,使用空腹血糖(n=133,010名无糖尿病参与者)和冠状动脉疾病(63,746例病例和130,681例对照)的最大规模全基因组关联研究汇总数据,参与者主要为欧洲血统。
  • 从最大规模2型糖尿病全基因组关联研究中排除与2型糖尿病相关的空腹血糖升高变异,并使用最大规模全基因组关联研究汇总数据排除对血脂、血压和肥胖等其他冠状动脉疾病风险因素有多效性效应的变异。
  • 使用弗雷明汉心脏研究数据验证孟德尔随机化工具并构建空腹血糖遗传风险评分。

主要发现

  • 在包含12个空腹血糖升高变异的工具变量分析中,空腹血糖每升高1 mmol/L,冠状动脉疾病比值比为1.43(95%CI 1.14-1.79)。
  • 排除异质性和对其他冠状动脉疾病风险因素有多效性效应的变异后,关联保持(OR 1.33 [95%CI 1.02-1.73])。
  • 12个空腹血糖升高变异未显著增加2型糖尿病风险(OR 1.05 [95%CI 0.91-1.23]),且2型糖尿病患病率在各空腹血糖遗传风险评分五分位间保持恒定(P=0.72)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study tested the hypothesis that genetically raised hyperglycemia increases coronary artery disease (CAD) risk separately from the risk conferred by type 2 diabetes as a whole. RESEARCH DESIGN AND METHODS: We conducted a Mendelian randomization (MR) analysis using summary-level statistics from the largest published meta-analyses of genome-wide association studies (GWAS) for fasting glucose (FG) (n = 133,010 participants free of diabetes) and CAD (n = 63,746 case subjects and 130,681 control subjects) of predominantly European ancestry. FG-increasing variants associated with type 2 diabetes from the largest GWAS for type 2 diabetes were excluded. Variants with pleiotropic effects on other CAD risk factors (blood lipids, blood pressure, and obesity) were excluded using summary-level data from the largest published GWAS. Data from the Framingham Heart Study were used to validate the MR instrument and to build an FG genetic risk score (GRS). RESULTS: In an instrumental variable analysis comprising 12 FG-raising variants, a 1 mmol/L increase in FG revealed an effect-size estimate of 1.43 CAD odds (95% CI 1.14-1.79). The association was preserved after excluding variants for heterogeneity and pleiotropic effects on other CAD risk factors (odds ratio [OR] 1.33 [95% CI 1.02-1.73]). The 12 FG-increasing variants did not significantly increase type 2 diabetes risk (OR 1.05 [95% CI 0.91-1.23]), and its prevalence was constant across FG GRS quintiles (P = 0.72). CONCLUSIONS: Our data support that genetic predisposition to hyperglycemia raises the odds of CAD separately from type 2 diabetes and other CAD risk factors. These findings suggest that modulating glycemia may provide cardiovascular benefit.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Merino J, Leong A, Posner DC, et al. Genetically Driven Hyperglycemia Increases Risk of Coronary Artery Disease Separately From Type 2 Diabetes. Diabetes Care. 2017. PMID: 28298470. doi:10.2337/dc16-2625

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。